RegenETP, Inc.
OTC: RGTPQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Richard Hague
- Employees
- 42
- Headquarters
- Salt Lake City, United States
- IPO year
- 1999
- Market cap
- $1.2M
- Website
- https://www.polarityte.com
Loading RGTPQ…
Loading profile data…Frequently asked questions about RGTPQ
What does RegenETP, Inc. (RGTPQ) do?
RegenETP, Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Salt Lake City, Utah. This company specializes in advancing and bringing to market a diverse array of regenerative tissue solutions and biological materials across the fields of medicine, biomedical engineering, and materials science within the United...
Where does RGTPQ trade?
RegenETP, Inc. (RGTPQ) trades on the Other OTC.
What sector is RGTPQ in?
RegenETP, Inc. (RGTPQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of RegenETP, Inc.?
Richard Hague is the chief executive officer of RegenETP, Inc. (RGTPQ).
Where is RegenETP, Inc. headquartered?
RegenETP, Inc. is headquartered in United States.
Does RGTPQ pay a dividend?
RegenETP, Inc. (RGTPQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RGTPQ go public?
RegenETP, Inc. (RGTPQ) completed its initial public offering in 1999.